Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03238365
Title Nivolumab With or Without Tadalafil in Treating Patients With Recurrent Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

hypopharynx cancer

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

paranasal sinus cancer

nasal cavity squamous cell carcinoma

Therapies

Nivolumab + Tadalafil

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.